日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of blood-derived exosomal tumor RNA signatures as noninvasive diagnostic biomarkers for multi-cancer: a multi-phase, multi-center study

鉴定血液来源外泌体肿瘤RNA特征作为多种癌症的非侵入性诊断生物标志物:一项多阶段、多中心研究

Wang, Fubo; Wang, Chengbang; Chen, Shaohua; Wei, Chunmeng; Ji, Jin; Liu, Yan; Liang, Leifeng; Chen, Yifeng; Li, Xing; Zhao, Lin; Shi, Xiaolei; Fang, Yu; Lu, Weimin; Li, Tianman; Liu, Zhe; Lu, Wenhao; Li, Tingting; Hu, Xiangui; Li, Mugan; Liu, Fuchen; He, Xing; Wen, Jiannan; Wang, Zuheng; Zhou, Wenxuan; Chen, Zehui; Hong, Yonggang; Zhang, Shaohua; Li, Xiao; Zhou, Rongbin; Mo, Linjian; Zhang, Duobing; Li, Tianyu; Zhang, Qingyun; Wang, Li; Wei, Xuedong; Yang, Bo; Huang, Shenglin; Zhang, Huiyong; Pang, Guijian; Ouyang, Liu; Wang, Zhenguang; Cheng, Jiwen; Xu, Bin; Mo, Zengnan

Knowledge-guided multi-level network modeling with experimental characterization identifies PRKCA as a novel biomarker and tumor suppressor triggering ferroptosis in prostate cancer.

通过知识引导的多级网络建模和实验表征,确定 PRKCA 是一种新型生物标志物和肿瘤抑制因子,可触发前列腺癌中的铁死亡

Lin Yuxin, Jia Zongming, Wu Jixiang, Yang Hubo, Chen Xin, Wang He, Wei Xuedong, Yan Wenying, Qi Xin, Huang Yuhua

CXCL14 in prostate cancer: complex interactions in the tumor microenvironment and future prospects

CXCL14在前列腺癌中的作用:肿瘤微环境中的复杂相互作用及未来展望

Tang, Lei; Chen, Xin; Hou, Jianquan; Wei, Xuedong

Targeting ferroptosis in prostate cancer management: molecular mechanisms, multidisciplinary strategies and translational perspectives

靶向铁死亡治疗前列腺癌:分子机制、多学科策略和转化应用前景

Yang, Hubo; Zhang, Xuefeng; Jia, Zongming; Wang, He; Wu, Jixiang; Wei, Xuedong; Huang, Yuhua; Yan, Wenying; Lin, Yuxin

Optimized Biopsy Strategy for Transition Zone Prostate Cancer With Enhanced Perilesional Sampling: A Retrospective Analysis and Clinical Trial Validation

采用增强病灶周围取样的前列腺移行区癌优化活检策略:回顾性分析和临床试验验证

Chen, Xin; Huang, Chen; Zhou, Chenchao; Li, Yu; Huang, Renpeng; Bao, Jie; Lin, Yuxin; Truß, Michael C; Hou, Jianquan; Huang, Yuhua; Wei, Xuedong

The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study

迪西他单抗维多汀联合免疫检查点抑制剂治疗转移性上尿路尿路上皮癌的疗效和安全性:一项多中心真实世界研究

Ng, Cheoklong; Jing, Taile; Yu, Shicheng; Ye, Jianjun; Zhang, Shun; Jia, Zhankui; Tang, Qi; Hu, Xiaoyi; Chen, Minfeng; Huang, Weiping; Wu, Jitao; Bi, Hai; Yan, Zejun; Shen, Haibo; Xiong, Wei; Liu, Zheng; Xiao, Jun; Zhang, Tao; Wei, Xuedong; Hu, Hailong; Yang, Qing; Yuan, Yichu; Huang, Zhiyang; Xue, Wei; Bao, Yige; Ding, Guoqing; Xia, Dan; Huang, Jiwei

Comprehensive analysis of the global, regional, and national burden of benign prostatic hyperplasia from 1990 to 2021

1990年至2021年全球、区域和国家良性前列腺增生负担的综合分析

Chen, Xin; Yang, Siyuan; He, Zhangxin; Chen, Zihao; Tang, Xinling; Lin, Yuxin; Huang, Yuhua; Hou, Jianquan; Wei, Xuedong

Novel Insights Into the Causal Association Between Dietary Factors and Risk of Urinary Calculus: A Multivariate and Two-Step Mendelian Randomization Analysis

饮食因素与泌尿系统结石风险因果关系的新见解:多元两步孟德尔随机化分析

Tang, Xinling; Qiu, Youjia; Song, Bingyi; Tao, Yuchen; Yin, Ziqian; Wang, Menghan; Ji, Na; Chen, Zhouqing; Wang, Zhong; Wei, Xuedong

Multiparametric MRI lesion dimension as a significant predictor of positive surgical margins following laparoscopic radical prostatectomy for transitional zone prostate cancer

多参数磁共振成像病灶大小是腹腔镜根治性前列腺切除术后移行区前列腺癌阳性切缘的重要预测因子

Chen, Xin; Chen, Yanzhong; Qian, Chengbo; Wang, Chaozhong; Lin, Yuxin; Huang, Yuhua; Hou, Jianquan; Wei, Xuedong

Metagenomic Next-Generation Sequencing-Assisted Risk Prediction and Stratification of Infections After Kidney Transplantation: A Case Study of COVID-19

基于宏基因组学二代测序技术的肾移植术后感染风险预测与分层:以新冠肺炎为例

Ye, Xin; Li, Chao; Zhou, Zheng; Yang, Jiangnan; Jiang, Hao; Hu, Linkun; Pan, Hao; Wei, Xuedong; Huang, Yuhua; Lin, Yuxin; Wang, Liangliang